- An estimated 108,070 cases of colon and 40,740 cases of rectal cancer are expected to occur in 2008.
- Colorectal cancer is the third most common cancer and second most common cause of cancer-related
deaths.
- An estimated 49,960 deaths from colon and rectal cancers are expected to occur in 2008, accounting for
nine percent of all cancer deaths.
Monoclonal antibodies approved to treat mCRC
- Avastin® (bevacizumab) blocks the growth of blood vessels to the tumor.
- Erbitux® (cetuximab) and Vectibix® (panitumumab) block the effect of hormone-like factors that promote
cancer cell growth.
|